Niaspan Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials

A Study of Psilocybin for Major Depressive Disorder (MDD)
Condition:   Depressive Disorder, Major Interventions:   Drug: Psilocybin;   Drug: Niacin Sponsors:   Usona Institute;   Bracket Global;   The EMMES Corporation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 7, 2019 Category: Research Source Type: clinical trials